NGB Laboratories

Surat, India Founded: 2017 • Age: 9 yrs
NGB Laboratories develops and manufactures a range of pharmaceutical products, including antibiotics.
Annual revenue $1.4M Latest available
Total funding - Funding intelligence
Employees 3 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About NGB Laboratories

NGB Laboratories is a company based in Surat (India) founded in 2017. It operates as a B2B. The company has 3 employees as of March 31, 2022. NGB Laboratories operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.

  • Headquarter Surat, India
  • Employees 3 as on 31 Mar, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Ngb Laboratories Private Limited
  • Date of Incorporation 17 Feb, 2014
  • Jurisdiction Surat, Gujarat, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.42 M (USD)
    144.05
    as on Mar 31, 2022
  • Net Profit
    -$1.95 M (USD)
    -60.94
    as on Mar 31, 2022
  • EBITDA
    -$1.79 M (USD)
    -142.25
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    3

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NGB Laboratories

Premium access

Detailed funding history for NGB Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NGB Laboratories

Investments
Premium access

Investment portfolio details for NGB Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NGB Laboratories

Premium access

Detailed financials for NGB Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Ngb Laboratories Comparisons

NGB Laboratories Primary company
Description
NGB Laboratories develops and manufactures a range of pharma...
Location
Surat, India
Founded Year
2017
Annual Revenue
$1.42 M (USD)
Net Profit
-$1.95 M (USD)
EBITDA
-$1.79 M (USD)
Employees
3
As of 2022
Premium access

Peer comparison for NGB Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NGB Laboratories

NGB Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Company specializing in development of Biosimilars
Locked Locked Locked
Polypeptide drugs and APIs are developed and manufactured.
Locked Locked Locked
Generics, nutraceuticals, and APIs are developed by Suanfarma.
Locked Locked Locked
Sterile pharmaceutical products are manufactured and contract services are provided.
Locked Locked Locked
CDMO and analytical services for peptide development are provided.
Locked Locked Locked
APIs and finished dosage forms are developed and manufactured.
Premium access

Detailed competitors of NGB Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Ngb Laboratories

Premium access

Complete news archive for NGB Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NGB Laboratories

NGB Laboratories was founded in 2017.

NGB Laboratories is headquartered in Surat, India. It is registered at Surat, Gujarat, India.

As of Mar 31, 2022, the latest employee count at NGB Laboratories is 3.

Annual revenue of NGB Laboratories is $1.42M as on Mar 31, 2022.

NGB Laboratories, based in Surat, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and antibiotics and medicines. NGB Laboratories develops and manufactures a range of pharmaceutical products, including antibiotics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

NGB Laboratories's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available